Literature DB >> 3007343

HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.

H Inoko, A Ando, K Tsuji, K Matsuki, T Juji, Y Honda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3007343     DOI： 10.1007/bf00377973

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  10 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha.

Authors:  H Inoko; A Ando; M Kimura; K Tsuji
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 4.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

5.  Clusters of HLA class II beta restriction fragments describe allelic series.

Authors:  D Cohen; I Le Gall; A Marcadet; M P Font; J M Lalouel; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 6.  HLA-D region molecules restrict proliferative T cell responses to antigen.

Authors:  E Thorsby; E Berle; H Nousiainen
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

7.  Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells.

Authors:  D Owerbach; A Lernmark; L Rask; P A Peterson; P Platz; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.

Authors:  T Juji; M Satake; Y Honda; Y Doi
Journal:  Tissue Antigens       Date:  1984-11

9.  Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.

Authors:  K Matsuki; T Juji; K Tokunaga; T Naohara; M Satake; Y Honda
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Genetic markers in narcolepsy.

Authors:  N Langdon; K I Welsh; M van Dam; R W Vaughan; D Parkes
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321
  10 in total
  10 in total

1.  The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.

Authors:  O Olerup; M Schaffer; J Hillert; C Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.

Authors:  R M Hershberg; P E Framson; D H Cho; L Y Lee; S Kovats; J Beitz; J S Blum; G T Nepom
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Analysis of HLA-D micropolymorphism by a simple procedure: RNA oligonucleotide hybridization.

Authors:  C Ucla; J J van Rood; J Gorski; B Mach
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Calcium influx and the Ca2+-calmodulin complex are involved in interferon-gamma-induced expression of HLA class II molecules on HL-60 cells.

Authors:  Y Koide; Y Ina; N Nezu; T O Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  HLA-DR2 negative narcolepsy.

Authors:  C Confavreux; L Gebuhrer; H Betuel; C Freidel; H Bastuji; G Aimard; M Devic; M Jouvet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

6.  Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

Authors:  K Matsuki; H Maeda; T Juji; H Inoko; A Ando; K Tsuji; Y Honda
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Authors:  David A Ostrov; Aimon Alkanani; Kristen A McDaniel; Stephanie Case; Erin E Baschal; Laura Pyle; Sam Ellis; Bernadette Pöllinger; Katherine J Seidl; Viral N Shah; Satish K Garg; Mark A Atkinson; Peter A Gottlieb; Aaron W Michels
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

8.  HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis.

Authors:  W M Howell; P R Evans; P J Wilson; M I Cawley; J L Smith
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

9.  Multiple sclerosis, sleep latencies and HLA antigens.

Authors:  L Rumbach; M M Tongio; J M Warter; M Collard; D Kurtz
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

10.  MHC class II sequences of an HLA-DR2 narcoleptic.

Authors:  C B Lock; A K So; K I Welsh; J D Parkes; J Trowsdale
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.